Location History:
- Toronto, CA (2016)
- Ellershouse, CA (2018)
Company Filing History:
Years Active: 2016-2018
Title: Scott C. Banfield: Innovator in Anti-Amyloid Compounds
Introduction
Scott C. Banfield is a notable inventor based in Ellershouse, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-amyloid compounds. With a total of 2 patents, his work is paving the way for potential treatments in neurodegenerative diseases.
Latest Patents
Banfield's latest patents include innovative compounds designed to combat amyloid-related conditions. One of his patents focuses on anti-amyloid compounds containing benzofurazan, which includes various compounds of Formula I. These compounds feature diverse substituents, such as 4-(pyrrolidin-1-yl)piperidin-1-yl and N,N,N-trimethylpropane-1,3-diamino, among others. Additionally, methods of treatment utilizing these compounds are also provided. Another patent details benzofurazan anti-amyloid compounds, which include a range of substituents and methods of treatment as well.
Career Highlights
Scott C. Banfield is currently associated with Treventis Corporation, where he continues to innovate in the field of pharmaceuticals. His work is characterized by a commitment to developing effective treatments for complex diseases.
Collaborations
Banfield collaborates with esteemed colleagues, including Mark A. Reed and Thomas Kuchurean Wood. Their combined expertise enhances the research and development efforts at Treventis Corporation.
Conclusion
Scott C. Banfield is a prominent figure in the realm of medicinal chemistry, with a focus on anti-amyloid compounds. His contributions are vital for advancing treatment options for neurodegenerative diseases.